The Centers for Disease Control and Prevention (CDC) and the Environmental Protection Agency (EPA) recommend using insect repellents to avoid being bitten by mosquitoes, ticks, and other arthropods that transmit disease-causing pathogens. Repellents applied to exposed skin should be used in conjunction with other preventive measures such as wearing long-sleeved shirts, pants, and socks and avoiding outdoor activities during peak mosquito-biting times.1 Some insect repellents are listed in Table 1.
Mosquitoes can transmit pathogens such as Zika, chikungunya, dengue, West Nile, eastern...
ISSUE
The FDA has cleared the Lumipulse G pTau217/β-Amyloid 1-42 Plasma Ratio (Fujirebio), a blood-based diagnostic test, for early detection of amyloid plaque pathology associated with Alzheimer's disease (AD) in adults ≥50 years old who are showing signs and symptoms of the disease. The new assay is the first blood test for amyloid biomarkers to become commercially available in the US. The Lumipulse G β-Amyloid Ratio (1-42/1-40), which measures amyloid biomarkers in cerebrospinal fluid (CSF), was cleared by the FDA in 2022.
BIOMARKERS IN AD ― Molecular biomarkers associated with amyloid beta protein deposition in the brain can assist in the diagnosis of AD. Confirmation of amyloid beta deposition is needed before starting treatment with the amyloid beta-directed monoclonal antibodies lecanemab (Leqembi)1 or donanemab (Kisunla).2 Currently available tests …